Seroprevalence of hepatitis B and C in subjects admitted to a cardiology clinics in Turkey.
A seroepidemiological study was conducted to assess the seroprevalence of hepatitis B surface antigen (HBs Ag) and antibodies to hepatitis C virus (Anti-HCV) in 14,196 patients hospitalized in our cardiology clinics. Threehundred and fifty five (355) patients (2.43%) were found to be positive for HBs Ag, a hundred and sixty six (166) patients (1.09%) were positive for Anti-HCV and ten patients (0.07%) were positive for both. The presence of HBs Ag and Anti-HCV was similar in patients living in rural and urban areas. The presence of risk factors was greater in the patients with Anti-HCV. The prevalences of HBs Ag and Anti-HCV were found to be comparable with those reported in other mediterranean countries in Europe.
Ozdemir
O
O
Cardiology Clinics, Türkiye Yüksek Ihtisas Hospital, Sihhiye Ankara, Turkey.
Arda
K
K
Soylu
M
M
Alyan
O
O
Demir
A D
AD
Kütük
E
E
D006509:Hepatitis B; D006526:Hepatitis C; D018937:Hepatitis C Antibodies; D006801:Humans; D016036:Seroepidemiologic Studies; D014421:Turkey / Q000453:epidemiology
D018937:Hepatitis C Antibodies